Terry J. Hamblin

18.0k citations

163 papers · 12.8k indexed · 2 hit papers · h-index 43

Genetics top 0.02%
Hematology top 0.05%
Pathology and Forensic Medicine top 0.1%
Immunology top 0.2%
Molecular Biology top 2%

Co-authors: David Oscier Freda K. Stevenson Zadie Davis Anne Gardiner John M. Bennett Ghulam Mufti Teresa Vallespı́Christopher Cox
Topics: Chronic Lymphocytic Leukemia Research (58 papers)Lymphoma Diagnosis and Treatment (37 papers)Immunodeficiency and Autoimmune Disorders (36 papers)
Cited by: Genetics Hematology Pathology and Forensic Medicine
Journals: Nature The Lancet Nature Medicine
Partner nations: United Kingdom United States Germany

In The Last Decade

Terry J. Hamblin

158 papers receiving 12.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

1997 3.2k citations Terry J. Hamblin, David Oscier et al. Blood profile →
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

1999 2.0k citations Terry J. Hamblin, David Oscier et al. Blood profile →

Peers

Countries citing papers authored by Terry J. Hamblin

Since Specialization

Citations

This map shows the geographic impact of Terry J. Hamblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry J. Hamblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry J. Hamblin more than expected).

Fields of papers citing papers by Terry J. Hamblin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry J. Hamblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry J. Hamblin. The network helps show where Terry J. Hamblin may publish in the future.

Co-authorship network of co-authors of Terry J. Hamblin

This figure shows the co-authorship network connecting the top 25 collaborators of Terry J. Hamblin. A scholar is included among the top collaborators of Terry J. Hamblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry J. Hamblin. Terry J. Hamblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia 2007 ·Blood ·Claire Dearden,Rachel Wade,Monica Else,Sue Richards,Don Milligan,Terry J. Hamblin,Daniel Catovsky	92
2	Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long‐term blood transfusions 2007 ·British Journal of Haematology ·Joseph Chacko,Dudley J. Pennell,Mark Tanner,Terry J. Hamblin,B. Wonke,Terry Levy,Peter Thomas,Sally Killick	74
3	Adaptor protein 3–dependent microtubule-mediated movement of lytic granules to the immunological synapse 2003 ·Nature Immunology ·Richard H. Clark,Jane C. Stinchcombe,Anna Day,(unknown),Sarah Booth,Giovanna Bossi,Terry J. Hamblin,E. Graham Davies,Gillian M. Griffiths	185
4	Historical aspects of chronic lymphocytic leukaemia 2000 ·British Journal of Haematology ·Terry J. Hamblin	4
5	From dendritic cells to tumour vaccines 1996 ·The Lancet ·Terry J. Hamblin	8
6	Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin 1995 ·The Lancet ·Ruth R. French,Alison L. Tutt,Martin J. Glennie,Terry J. Hamblin,A.J. Bell	25
7	1st International Conference on Reversal of Multidrug Resistance in Cancer 1995 ·Leukemia Research ·Terry J. Hamblin	4
8	Pattern of usage of the VH4–21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching 1995 ·Molecular Immunology ·Caroline Chapman,Myfanwy B. Spellerberg,Terry J. Hamblin,Freda K. Stevenson	19
9	Use of a Phage Expression System to Produce Fabs from Human Autoanti‐DNA Antibodies Encoded by the V_H4–21 Gene Segment 1995 ·Annals of the New York Academy of Sciences ·Caroline Chapman,C. Ian Mockridge,Myfanwy B. Spellerberg,David Isenberg,Terry J. Hamblin,Freda K. Stevenson	0
10	Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes 1994 ·British Journal of Haematology ·Delin Zhu,Robert E. Hawkins,Terry J. Hamblin,Freda K. Stevenson	97
11	Utilization of the VH4-21 Gene Segment by Anti-DNA Antibodies from Patients with Systemic Lupus Erythematosus 1993 ·Journal of Autoimmunity ·Freda K. Stevenson,Celia M. Longhurst,Caroline Chapman,Michael R. Ehrenstein,Myfanwy B. Spellerberg,Terry J. Hamblin,(unknown),David S. Latchman,David Isenberg	96
12	The treatment of acute myeloid leukaemia preceded by the myelodysplastic syndrome 1992 ·Leukemia Research ·Terry J. Hamblin	33
13	Idiotypic vaccination against B-cell lymphoma leads to dormant tumour 1991 ·Cellular Immunology ·(unknown),H M McBride,Andrew J.T. George,Terry J. Hamblin,Freda K. Stevenson	35
14	Interleukin 2: Author's Reply 1990 ·BMJ ·Terry J. Hamblin	1
15	Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the bournemouth score 1989 ·Leukemia Research ·David Oscier,(unknown),Susan Darlow,Ann Figes,(unknown),Terry J. Hamblin	19
16	TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKAEMIA WITH LOW DOSE ETOPOSIDE 1989 ·British Journal of Haematology ·David Oscier,(unknown),Terry J. Hamblin,(unknown)	27
17	Differentiation induction in myelodysplasia and acute myeloid leukaemia: Use of synergistic drug combinations 1987 ·Leukemia Research ·G. E. Francis,G J Mufti,S. Knowles,J. J. Berney,(unknown),Lorna M. Secker‐Walker,Terry J. Hamblin	17
18	Monocytic skin infiltration in chronic myelomonocytic leukaemia 1986 ·Clinical & Laboratory Haematology ·J. A. Copplestone,David Oscier,G J Mufti,Terry J. Hamblin	25
19	Immunological reason for chronic ill health after infectious mononucleosis. 1983 ·BMJ ·Terry J. Hamblin,Jibran Hussain,Arne N. Akbar,(unknown),J. L. Smith,David Jones	42
20	Anti-keratin antibodies in rheumatoid arthritis. 1979 ·BMJ ·Brian J. Young,R K Mallya,R. D. G. Leslie,(unknown),Terry J. Hamblin	252

About Terry J. Hamblin

Terry J. Hamblin is a scholar working on Genetics, Hematology and Immunology, having authored 163 papers that have together received 12.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (58 papers), Lymphoma Diagnosis and Treatment (37 papers) and Immunodeficiency and Autoimmune Disorders (36 papers). The work is most often cited by research in Genetics (7.6k citations), Hematology (5.3k citations) and Pathology and Forensic Medicine (4.7k citations). Terry J. Hamblin has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include David Oscier, Freda K. Stevenson, Zadie Davis, Anne Gardiner, John M. Bennett, Ghulam Mufti, Teresa Vallespı́, Christopher Cox, Pierre Fenaux and Pierre Morel. Their work appears in journals such as Nature, The Lancet and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact